Provided by Tiger Trade Technology Pte. Ltd.

CytomX Therapeutics

4.56
+0.13503.05%
Volume:3.07M
Turnover:14.17M
Market Cap:984.69M
PE:-30.37
High:4.79
Open:4.40
Low:4.37
Close:4.42
52wk High:8.21
52wk Low:0.4000
Shares:216.18M
Float Shares:113.00M
Volume Ratio:0.52
T/O Rate:2.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1500
EPS(LYR):-0.1500
ROE:-35.25%
ROA:-8.99%
PB:9.95
PE(LYR):-30.37

Loading ...

Feb 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 16, 2024

Correspondence

Form CORRESP - Correspondence
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2024

Major Issues Report

Form 8-K - Current report